INTECH Investment Management’s scPharmaceuticals SCPH Stock Holding History

INTECH Investment Management’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,521	Closed	-$88K	–	2438
2025 Q3	$88K	Sell	15,521 -1,818	-10%	-$9.31K	﹤0.01%	2295
2025 Q2	$66.1K	Sell	17,339 -12,972	-43%	-$40.3K	﹤0.01%	2381
2025 Q1	$79.7K	Buy	30,311 +17,345	+134%	+$56.5K	﹤0.01%	2362
2024 Q4	$45.9K	Buy	+12,966	New	+$49.7K	﹤0.01%	2336

INTECH Investment Management's SCPH Position: Q4 2025 in Review

INTECH Investment Management sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 15,521 shares — an estimated $88K sold.

INTECH Investment Management first reported a position in SCPH in Q4 2024 and held it in 4 quarters. The position peaked at $88K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

INTECH Investment Management reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
INTECH Investment Management sold 15,521 scPharmaceuticals shares in Q4 2025, an estimated $88K.
INTECH Investment Management first reported a position in scPharmaceuticals in Q4 2024 and held it in 4 quarters.
INTECH Investment Management's scPharmaceuticals position peaked at $88K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on INTECH Investment Management's 13F filing for Q4 2025, filed 10 Feb 2026.